Loading...
Targeting Molecular Aberrations in Urothelial Carcinoma: Are We Almost There?
Advances in tumor biology and cancer genetics have led to the development of effective targeted therapies in oncology over the past decade. However, targeted drug development for urothelial carcinoma has been slower than for some other malignancies. The path forward in drug development is through a...
Na minha lista:
| Udgivet i: | Am Soc Clin Oncol Educ Book |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6776417/ https://ncbi.nlm.nih.gov/pubmed/23714499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EdBook_AM.2013.33.195 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|